General
EU gives green light to AstraZeneca COVID-19 vaccine despite German concerns
Europe’s medicines regulator has approved AstraZeneca and Oxford University’s COVID-19 vaccine for people over the age of 18, making it the third vaccine to be cleared for use in the European Union.
Key points:
- The European Medicines Agency said the jab had an efficacy of around 60 per cent in trials
- It said it expected the vaccine would offer protection to elderly people
- Germany had recommended the vaccine only be given to people aged between 18 and 64
The AstraZeneca vaccine demonstrated an efficacy of around 60 per cent in the trials on which the decision was based, the European Medicines Agency (EMA) said in a statement.
The 60 per cent efficacy rate raised some concerns the AstraZeneca vaccine offers less protection than ones already…
-
Noosa News23 hours agoMan allegedly killed at teenage house party identified as co-founder of Universal Store
-
Noosa News24 hours agoRising talent shine at Noosa International Surfilm Festival 2025
-
Business19 hours agoHow you could turn $10k into $100k with ASX shares
-
Noosa News21 hours agoPolice charge teen with alleged murder of Universal Store co-founder